Trump to expedite review of psychedelic substances following Joe Rogans endorsement

Here is a rewritten version of the news article in a neutral newsroom style:

US President Donald Trump has accelerated the review process for psychedelic substances, including ibogaine, after receiving a text from Joe Rogan. The development comes as part of an executive order signed by Trump.

According to reports, Trump’s administration has taken steps to loosen restrictions on psychedelic drugs. This includes increasing access to substances such as LSD, psilocybin, and ibogaine for research purposes.

The move is seen as a significant shift in the country’s approach to psychedelics. The executive order aims to facilitate further study of these substances, which could potentially lead to new treatments for various medical conditions.

Trump’s decision has been met with interest from researchers and experts in the field. While details about the review process are still emerging, it is clear that the administration is taking a more open-minded approach to psychedelics than in the past.

The development comes as part of a broader trend towards increased research into psychedelic substances. Several high-profile figures, including Joe Rogan, have publicly advocated for greater access to these substances for therapeutic purposes.

As the review process moves forward, it remains to be seen how this will impact the country’s approach to psychedelics.

Source: Google News World